Fisher Asset Management LLC decreased its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 941,269 shares of the oil and gas company's stock after selling 48,998 shares during the period. Fisher Asset Management LLC owned about 2.00% of Core Laboratories worth $16,293,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the company. Confluence Investment Management LLC lifted its holdings in shares of Core Laboratories by 0.4% during the 4th quarter. Confluence Investment Management LLC now owns 136,359 shares of the oil and gas company's stock worth $2,360,000 after acquiring an additional 599 shares during the period. Tidal Investments LLC lifted its stake in Core Laboratories by 1.7% during the third quarter. Tidal Investments LLC now owns 43,862 shares of the oil and gas company's stock worth $813,000 after purchasing an additional 716 shares during the period. Ridgewood Investments LLC boosted its holdings in Core Laboratories by 4.6% during the fourth quarter. Ridgewood Investments LLC now owns 32,612 shares of the oil and gas company's stock valued at $565,000 after purchasing an additional 1,428 shares in the last quarter. Isthmus Partners LLC grew its stake in shares of Core Laboratories by 18.8% in the 3rd quarter. Isthmus Partners LLC now owns 10,620 shares of the oil and gas company's stock valued at $197,000 after purchasing an additional 1,682 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in shares of Core Laboratories by 5.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company's stock worth $765,000 after buying an additional 2,267 shares in the last quarter. Institutional investors own 97.81% of the company's stock.
Core Laboratories Price Performance
Shares of CLB traded up $0.81 on Friday, hitting $14.90. The company's stock had a trading volume of 404,487 shares, compared to its average volume of 334,916. The company has a market capitalization of $697.68 million, a PE ratio of 22.57, a PEG ratio of 0.99 and a beta of 2.38. Core Laboratories Inc. has a fifty-two week low of $12.95 and a fifty-two week high of $25.13. The company has a 50 day moving average price of $17.42 and a 200 day moving average price of $18.47. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71.
Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, hitting analysts' consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. On average, research analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.
Core Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date was Monday, February 10th. Core Laboratories's dividend payout ratio is presently 6.06%.
Wall Street Analyst Weigh In
CLB has been the topic of a number of analyst reports. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Citigroup boosted their target price on shares of Core Laboratories from $14.00 to $15.00 and gave the company a "sell" rating in a research note on Thursday, February 20th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $17.25.
Get Our Latest Report on CLB
About Core Laboratories
(
Free Report)
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Articles
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
